Figures & data
Table 1. Clinico-pathological features of pediatric ALL patients.
Figure 1. Expression levels of: (A) miR-100 and (B) miR-210 in BM aspirate of pediatric ALL patients compared to normal controls. ROC analysis of (C) miR-100 and (D) miR-210 for the diagnosis of pediatric ALL patients.
![Figure 1. Expression levels of: (A) miR-100 and (B) miR-210 in BM aspirate of pediatric ALL patients compared to normal controls. ROC analysis of (C) miR-100 and (D) miR-210 for the diagnosis of pediatric ALL patients.](/cms/asset/25af0775-aa50-4013-8896-4a1a2f119366/yhem_a_1843753_f0001_oc.jpg)
Table 2. ROC analysis for diagnosis of pediatric ALL with miRNA-210 and miRNA-100.
Table 3. Association between miRNA 210, miRNA 100 and patients’ characteristics.
Figure 2. Association between (A) miR-210, (B) miR-100 and MRD of the assessed pediatric ALL patients.
![Figure 2. Association between (A) miR-210, (B) miR-100 and MRD of the assessed pediatric ALL patients.](/cms/asset/92d89bc7-d4a0-4795-824e-84d0d78e0cfb/yhem_a_1843753_f0002_oc.jpg)